Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
06/2005
06/23/2005WO2005057207A1 Trityl derivatives for enhancing mass spectrometry
06/23/2005WO2005056545A1 Sulfoxyalkylthiophene compound and process for producing the same
06/23/2005WO2005056528A1 Carboxamide derivatives
06/23/2005WO2005056516A1 Biphenyl derivatives useful as ligands that activate the rar receptors, process for preparing them and use thereof in human medicine and in cosmetics
06/23/2005WO2005056510A2 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics
06/23/2005WO2005055941A2 Novel m3 muscarinic acetylcholine receptor antagonists
06/23/2005WO2005040121A3 Amides that inhibit vanilloid receptor subtype 1 (vr1) receptor
06/23/2005WO2005035488A3 Thiophene-2-carboxamide derivatives and use thereof as cannabinoid cb-1 receptor antagonists
06/23/2005WO2005033056A3 Triphenylethylene compounds as selective estrogen receptor modulators
06/23/2005WO2005000406A3 Treatment of amyloid- and epileptogenesis-associated diseases
06/23/2005WO2004046094A9 Histone deacetylase inhibitors
06/23/2005WO2002068380A8 Synthetic excitatory amino acids
06/23/2005US20050137402 Process for preparing alkynyl-substituted aromatic and heterocyclic compounds
06/23/2005US20050137396 Process for preparing benzoic acids
06/23/2005US20050137249 Cyclization at the 5,6-position of the benzo[e]naphtho[3,2-h]azulene, oxepane or thiepane with a mercaptoacetic acid ester followed by etherification, amination or sulfiding at the 2-position; antiarthritic and antiinflammatory agents, analgesics; biosynthesis inhibitors of interleukin-1; nontoxic
06/23/2005US20050137234 Histone deacetylase inhibitors
06/23/2005US20050137230 Factor Xa-inhibitors; preventing thromboembolic illnesses and tumors; 2-amino-N-(2'-methylsulfonylbiphenyl-4-yl)-3-phenylpropionamide
06/23/2005US20050137200 Potassium channel modulators; antiarrhythmia agents
06/23/2005US20050137192 Use of compounds such as 4-bromo-9a-butyl-8-chloro-6-fluoro-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one to treat depression
06/23/2005US20050137191 Nitrate esters and their use for mitigating cellular damage
06/23/2005DE102004053279A1 Benzofuran and benzothiophene derivatives, useful as components of liquid crystal media for electro-optical display devices are new
06/23/2005CA2549548A1 Carboxamide derivatives
06/23/2005CA2549273A1 Novel m3 muscarinic acetylcholine receptor antagonists
06/23/2005CA2545112A1 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics
06/22/2005EP1544202A1 Novel herbicides, usage thereof, novel thienopyrimidine derivatives, intermediates of the same, and process for production thereof
06/22/2005EP1542985A2 Processes for the preparation of heterocyclic hydroxyamines and intermediates and catalysts for use therein
06/22/2005EP1542967A1 Amide and sulfonamide ligands for the estrogen receptor
06/22/2005EP1542966A1 Aromatic liver x-receptor modulators
06/22/2005EP1100763B1 Diketoacid-derivatives as inhibitors of polymerases
06/22/2005CN1630637A Novel arylheteroalkylamine derivatives
06/22/2005CN1630635A Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these
06/22/2005CN1630629A 酯化合物及其医药用途 Ester compounds and pharmaceutical use
06/22/2005CN1629139A Dialkyl and diaryl tetrasubstituted heterocyclic compounds, preparing process and use thereof
06/22/2005CN1207056C Peptide-containing & alpha; -ketoamide cysteine and serine protease inhibitors
06/22/2005CN1206914C Pesticide containing 0-benzyl oximeether derivative and its use
06/21/2005US6908935 Calcium receptor modulating agents
06/21/2005US6908923 Compositions and methods for treating heart failure
06/21/2005US6908722 Contains fluoroalkyl groups; for use in a chemically amplified radiation-sensitive resin mixture, gives high transparency, no bioaccumulation, high acidity of produced acid, high boiling point, short diffusion length
06/16/2005WO2005054226A1 Benzofurans and benzothiophenes
06/16/2005WO2005054225A1 Antidiabetic compounds comprising benzofuran and benzothiophene derivatives
06/16/2005WO2005054180A1 Antiamyloid phenylsulfonamides: n-cycloalkylcarboxamides derivatives
06/16/2005WO2005054176A1 Peroxisome proliferator activated receptor modulators
06/16/2005US20050131056 2- thia-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
06/16/2005US20050131018 Acetylene derivatives as inhibitors of histone deacetylase
06/16/2005US20050130973 3-Methyl-2-[4'-(pyridin-3-ylmethoxymethyl)-biphenyl-4-sulfonylamino]-butyric acid; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis
06/16/2005US20050130966 Sodium channel modulators
06/16/2005US20050130964 e.g 8-oxa-1-thia-benzo[e]naphtho[3,2-h]azulene-2-carboxylic acid ethyl ester; rheumatoid arthritis
06/16/2005US20050130843 Substituted thien-3-yl-sulphonylamino(thio)carbonyl-triazolin(ethi)ones
06/16/2005US20050130221 Synthesis for the preparation of compounds for screening as potential tubulin binding agents
06/16/2005DE10353093A1 Unsymmetrische lineare organische Oligomere Asymmetrical linear organic oligomers
06/16/2005CA2547791A1 Therapeutics use of pyridinium compounds to modulate naadp activity
06/16/2005CA2547212A1 Peroxisome proliferator activated receptor modulators
06/16/2005CA2546647A1 Antidiabetic compounds comprising benzofuran and benzothiophene derivatives
06/15/2005EP1541569A1 Process for producing n-monoalkyl-3-hydroxy-3-(2-thienyl)propanamine and intermediate
06/15/2005EP1541198A1 Cycloalkyl compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
06/15/2005EP1539732A1 Novel compounds
06/15/2005EP1539731A1 Novel compounds
06/15/2005EP1539730A1 Novel compunds, pharmaceutical compositions containing same, and methods of use for same
06/15/2005EP1539717A2 Microbiocidal (e.g fungicidal) 1,2,3-triazole derivatives
06/15/2005EP1539697A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs
06/15/2005EP1539693A1 Cannabinoid receptor agonists
06/15/2005EP1539685A1 Mcp-1 receptor antagonists and method of use thereof
06/15/2005EP1539683A2 Phenol derivatives and their use as rotamase inhibitors
06/15/2005EP1539678A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands
06/15/2005EP1539673A1 PROCESS FOR THE PREPARATION OF i N /i -MONOSUBSTITUTED &bgr;-AMINO ALCOHOLS
06/15/2005EP1539662A1 Cannabinoid receptor ligands
06/15/2005EP1539147A1 Methods of treating microbial infections in humans and animals
06/15/2005EP1373240B1 Retinoid x receptor modulators
06/15/2005EP1278740B1 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
06/15/2005EP1256576B1 Fused imidazolium derivatives
06/15/2005EP0991654B1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same
06/15/2005CN1628268A Sulfonate derivatives and the use therof as latent acids
06/15/2005CN1628097A Astaxanthin esters
06/15/2005CN1628095A Diamine derivative, process for producing the same, and bactericide containing the same as active ingredient
06/15/2005CN1626501A Process for preparing optically active nitro compounds and cyano compounds
06/15/2005CN1626482A Methods, systems and catalysts for use in aromatic alkylation reactions
06/15/2005CN1206228C N-heterocyclic derivatives as NOS inhibitors
06/15/2005CN1206218C Aryl phenyl substituted cyclic ketoenols
06/14/2005US6906094 1,2,4-tribsubstituted benzenes as inhibitors of 15-lipoxygenase
06/14/2005US6906092 Method of inhibiting matrix metalloproteinases
06/14/2005US6906086 Methods for inhibiting bone loss
06/14/2005US6906073 Piperazine CCR-3 receptor antagonists
06/14/2005US6906072 Central nervous system disorders
06/14/2005US6906063 For therapy and prophylaxis of thrombosis in a mammal
06/14/2005US6905804 Charge transport material comprising a fluorenone hydrazone having a) least two fluorenone alkylsulfonylphenylhydrazone groups, b) at least two fluorenone pyrrolylhydrazone groups, c) at least two fluorenone benzotriazolylhydrazone groups, d)
06/14/2005CA2274591C Benzothiophenecarboxamide derivatives and pgd2 antagonists comprising them
06/14/2005CA2150229C Nitric esters having a pharmacological activity and process for their preparation
06/14/2005CA2143348C The methylation of organic compounds
06/14/2005CA2112017C Use of benzothiophenes for lowering serum cholesterol
06/09/2005WO2005051940A2 Vitamin d receptor modulators
06/09/2005WO2005051895A1 Organic compounds
06/09/2005WO2005051894A1 Novel salicylic anilides
06/09/2005WO2005051890A1 Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to gpr40
06/09/2005WO2005051889A1 M-diaminobenzoles and the acidic adducts thereof and use thereof in colouring agents
06/09/2005WO2005051373A1 Receptor function regulating agent
06/09/2005WO2005028425A3 Amidines and derivatives thereof and pharmaceutical compositions containing them
06/09/2005US20050124814 Addition polymers
06/09/2005US20050124698 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
06/09/2005US20050124682 Such as N-{2-[5-(methylthio)-1H-indol-3-yl]ethyl}acetamide for treatment of disorders of the melatoninergic system; hormone replacement therapy
06/09/2005US20050124671 Benzylcycloalkyl amines as modulators of chemokine receptor activity
1 ... 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 ... 329